Top Risks for 2026 – Part 1 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1210

Asrar Qureshi’s blog post discusses the Eurasia Group’s report on top geopolitical risks for 2026, highlighting significant shifts, including U.S. political instability, the emergence of an “ElectroState” led by China, and a revised U.S. foreign policy focus on Latin America. It emphasizes interconnected global tensions and challenges facing Europe and NATO.
Share
View Post

Three Important Tech Stories of 2024 – Asrar Qureshi’s Blog Post 1050

Asrar Qureshi’s Blog Post 1050 highlights significant advancements in AI during 2024, including the launch of OpenAI’s o1 reasoning model, NVIDIA’s rise as the most valuable AI company, and the EU’s introduction of the AI Act for regulatory oversight. These developments reflect both opportunities and challenges in AI’s evolution.
Share
View Post

Artificial General Intelligence (AGI) – Asrar Qureshi’s Blog Post #1041

Asrar Qureshi’s blog post discusses the concept of Artificial General Intelligence (AGI), which aims to replicate human cognitive abilities. While current AI systems are limited, AGI promises significant advancements and challenges in various sectors, including healthcare and economics. Ethical considerations and the timeline for AGI’s emergence remain uncertain, requiring careful development and collaboration.
Share
View Post

Ethical Issues in Pharmaceutical Marketing – Asrar Qureshi’s Blog Post #1005

Asrar Qureshi’s blog post discusses the unique ethical challenges of pharmaceutical marketing, emphasizing the distinction between customers (doctors) and consumers (patients). It highlights issues like misleading advertising, targeting vulnerable populations, off-label promotions, exaggerated disease prevalence, and undue influence on healthcare decision-making. Collaboration is essential to promote ethical practices in the industry.
Share